Because up to 20% of adults over 60and many younger patients on metformin, PPIs, or plant-based dietsharbor low-normal B12, routine screening in dizzy patients often uncovers correctable deficits
Research shows GHK-Cu's therapeutic dose is approximately 300-fold below its toxic threshold
Following neurological involvement, maintenance injections are typically given every two months for life
In the Phase 3 REDEFINE-1 trial, adding cagrilintide to semaglutide pushed average weight loss from 14.9% to 20.4%
Because the results depend heavily on the exact treatment settings (waveform, intensity, frequency, and duration), it is important for clinicians to carefully document the treatment plan and base recommendations on high-quality research whenever possible